Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Express Scripts
Colorcon
Baxter
Chinese Patent Office
Merck
Federal Trade Commission
US Army

Generated: June 19, 2018

DrugPatentWatch Database Preview

TIMOLIDE 10-25 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Timolide 10-25, and what generic alternatives are available?

Timolide 10-25 is a drug marketed by Merck and is included in one NDA.

The generic ingredient in TIMOLIDE 10-25 is hydrochlorothiazide; timolol maleate. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; timolol maleate profile page.
Summary for TIMOLIDE 10-25
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:TIMOLIDE 10-25 at DailyMed
Drug patent expirations by year for TIMOLIDE 10-25

US Patents and Regulatory Information for TIMOLIDE 10-25

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck TIMOLIDE 10-25 hydrochlorothiazide; timolol maleate TABLET;ORAL 018061-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TIMOLIDE 10-25

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck TIMOLIDE 10-25 hydrochlorothiazide; timolol maleate TABLET;ORAL 018061-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Merck TIMOLIDE 10-25 hydrochlorothiazide; timolol maleate TABLET;ORAL 018061-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Medtronic
Harvard Business School
Merck
Covington
Farmers Insurance
AstraZeneca
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.